Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
383 Leser
Artikel bewerten:
(2)

Amelia Announces $175 Million Investment from BuildGroup and Monroe Capital

Finanznachrichten News

Trusted AI leader helps customers navigate chatbot frenzy.

NEW YORK, March 7, 2023 /PRNewswire/ -- Amelia, the enterprise leader in Trusted AI, today announced a $175 Million Strategic Investment from BuildGroup and Monroe Capital that will provide financial capital and business leadership. Goldman Sachs & Co LLC and TD Cowen advised the Company on its raise.

This investment comes at a critical time as many companies are considering how to navigate the OpenAI-enabled chatbot market frenzy without getting cut by bleeding-edge technology. Amelia offers a unique industry viewpoint on this hype cycle, moving beyond the limitations of ChatGPT by offering an enterprise AI option that delivers outcomes customers can trust. Amelia's market-leading technology is recognized by analysts as a safe way for enterprises to use cutting-edge AI to deliver better outcomes to customers.

Lanham Napier, BuildGroup's CEO, will join Amelia's Board as Chairman and will step into an active role on the leadership team. Amelia Founder Chetan Dube will focus his leadership on the Company's research and development, and technical elements of delivery.

"Twenty years ago I was blessed to be CEO of Rackspace and help build the Company from $1.5 million to $1.5 billion in sales at the dawn of the internet age. We now find ourselves at the beginning of the AI age, and Amelia is the right company to lead this new market by helping businesses utilize AI to deliver greater outcomes to their customers. I'm thrilled to jump into the fray with Amelians, and I'm excited for what we have the opportunity to build together," said Lanham Napier.

Chetan Dube commented, "For Amelia's customers, employees and partners - and for me personally - this partnership is a long time coming. Amelia has been at the forefront of leveraging AI for the betterment of people, the global workforce and ultimately our planet. This investment by our new partners will bring Amelia into a new era of growth driven by our Trusted AI solutions. We are grateful to BuildGroup and Monroe Capital for joining us on this journey."

About Amelia

Amelia is the enterprise leader in Trusted AI. As an AI pioneer, Amelia has a proven track record of innovation in automation and Conversational AI. Amelia's platform captures the rapid innovation of AI ecosystems and transforms these innovations into enterprise-grade products. Enterprises use Amelia to drive revenue in conversational experiences and enable productivity through operations automation. Amelia is consistently recognized by analyst firms as a market leader. Enterprises trust Amelia's products and solutions to serve customers globally. Learn more at amelia.ai.

Media Contact:
media@amelia.ai

About BuildGroup

Led by former Rackspace CEO Lanham Napier, BuildGroup invests in high-growth technology companies. Backed by entrepreneurial families, BuildGroup applies a long-term investment approach, unique operating skills, and partnerships with its network of successful business owners. BuildGroup's portfolio includes Anaconda, Andela, Casetext, Cybrary, Fiix Software, Flowspace and Lendio. For more information on BuildGroup, visit www.buildgroup.com.

About Monroe Capital

Monroe Capital LLC ("Monroe") is a premier boutique asset management firm specializing in private credit markets across various strategies, including direct lending, asset-based lending, specialty finance, opportunistic and structured credit, and equity. Since 2004, the firm has provided capital solutions to clients in the U.S. and Canada. Monroe prides itself on being a value-added, user-friendly partner to business owners, management, and both private equity and independent sponsors. Monroe's platform offers a wide variety of investment products for both institutional and high net worth investors with a focus on generating high quality "alpha" returns irrespective of business or economic cycles. For more information, visit https://www.monroecap.com/.

Media Contact:
Mark Solovy
msolovy@monroecap.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/amelia-announces-175-million-investment-from-buildgroup-and-monroe-capital-301764525.html

© 2023 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.